日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Dietary glucuronolactone alleviates hepatic lipid accumulation via the enterohepatic axis in laying hens

膳食中添加葡萄糖醛酸内酯可通过肠肝轴减轻蛋鸡肝脏脂质蓄积。

期刊:
影响因子:
doi:10.1186/s40104-025-01350-2
Shen, Yiru; Chen, Jinglong; Xiao, Yunqi; Shi, Shourong
肠肝轴
代谢
发表日期：2026
文献求助 收藏

First-line treatment of hepatocellular carcinoma: a propensity-matched analysis of tyrosine kinase inhibitors combined with TACE, with or without PD-1 inhibitors

肝细胞癌一线治疗：酪氨酸激酶抑制剂联合TACE（有或无PD-1抑制剂）的倾向性匹配分析

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2025.1533471
Shen, Yanjun; Xu, Yawen; Teng, Ying; Ding, Xiaoyan; Chen, Jinglong
肿瘤
肿瘤免疫
信号转导
细胞生物学
PD-1
发表日期：2025
文献求助 收藏

Association between egg consumption and risk of obesity: A comprehensive review: EGG CONSUMPTION AND OBESITY

鸡蛋摄入量与肥胖风险之间的关联：一项综合综述：鸡蛋摄入量与肥胖

期刊:Poultry Science
影响因子:4.2
doi:10.1016/j.psj.2024.104660
Chen, Jinglong; Pei, Bixuan; Shi, Shourong
肥胖
代谢
发表日期：2025
文献求助 收藏

Accuracy and reliability of 3D cephalometric landmark detection with deep learning

基于深度学习的三维头影测量标志点检测的准确性和可靠性

期刊:European Journal of Medical Research
影响因子:3.4
doi:10.1186/s40001-025-03198-8
Liu, Boyan; Liu, Chang; Xiong, Yutao; Zhu, Hailin; Zeng, Wei; Chen, Jinglong; Guo, Jixiang; Liu, Wei; Tang, Wei
发表日期：2025
文献求助 收藏

Recurrence of hepatocellular carcinoma in patients with high HALP score in TACE combined with ablation

TACE联合消融治疗后，HALP评分高的患者肝细胞癌复发率较高

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1609260
Fang, Da; Yin, Xue; Ding, Xiaoyan; Chen, Jinglong; Cui, Xiongwei; Hu, Caixia
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Mono-TKI and TKI Plus ICI in Unresectable Hepatocellular Carcinoma Progression on First-Line Treatment of Lenvatinib: A Real-World Study

单药TKI和TKI联合ICI治疗一线乐伐替尼治疗后进展的不可切除肝细胞癌：一项真实世界研究

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.70711
Yin, Xue; Deng, Na; Chen, Jinglong; Ding, Xiaoyan
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Patients with uHCC and Child-Pugh B8/9 also benefit from a combination of antiangiogenic agents and PD-1 inhibitors: a multicenter real-world study

一项多中心真实世界研究表明，Child-Pugh B8/9级肝细胞癌患者也能从抗血管生成药物和PD-1抑制剂的联合治疗中获益：

期刊:Acta Oncologica
影响因子:2.2
doi:10.2340/1651-226X.2025.42652
Ding, Xiaoyan; Yin, Xue; Zheng, Linlin; Zhou, Lin; Hu, Junke; Sun, Wei; Sun, Lei; Shen, Yanjun; Teng, Ying; Xu, Yawen; Li, Wendong; Liu, Mei; Chen, Jinglong
肿瘤
肿瘤免疫
细胞生物学
血管生成
PD-1
发表日期：2025
文献求助 收藏

Efficacy and Safety of First-Line Chemotherapy-Based Combination Therapy for Patients With Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis

一线化疗联合治疗广泛期小细胞肺癌患者的疗效和安全性：系统评价和网络荟萃分析

期刊:Clinical Medicine Insights-Oncology
影响因子:1.9
doi:10.1177/11795549251364320
Zhao, Qingfang; Liu, Xiaomin; Yu, Minghua; Chen, Jinglong
细胞生物学
肿瘤
肿瘤免疫
肺癌
发表日期：2025
文献求助 收藏

Aging-related inflammatory and metabolic disorder in the novel mutation of colony-stimulating factor-1 receptor (csf1r) (P853T/+) in CSF1R-microglial encephalopathy

CSF1R-小胶质细胞脑病中集落刺激因子-1受体（CSF1R）新突变（P853T/+）引起的衰老相关炎症和代谢紊乱

期刊:Genes and Diseases
影响因子:
doi:10.1016/j.gendis.2024.101289
Wang, Xiaohong; Wang, Yanli; Jiang, Tianlin; Jiang, Jiwei; Wang, Linlin; Yang, Shiyi; Sun, Mengfan; Zhang, Yuan; Jia, Ziyan; Li, Wenyi; Ren, Qiwei; Zhang, Cuicui; Liu, Jianjian; Zhu, Yinwei; Zhao, Min; Jiang, Shirui; Zhang, Huiying; Chen, Jinglong; Xu, Jun
胶质细胞
CSF1
炎症
炎症/感染
信号转导
神经科学
代谢
衰老
细胞生物学
CSF1R
发表日期：2025
文献求助 收藏

Prognostic model for predicting recurrence in hepatocellular carcinoma patients with high systemic immune-inflammation index based on machine learning in a multicenter study

基于机器学习的多中心研究构建了预测全身免疫炎症指数高的肝细胞癌患者复发的预后模型

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2024.1459740
Lu, Ningning; Sheng, Shugui; Xiong, Yiqi; Zhao, Chuanren; Qiao, Wenying; Ding, Xiaoyan; Chen, Jinglong; Zhang, Yonghong
肿瘤
炎症
肿瘤免疫
炎症/感染
细胞生物学
免疫/内分泌
发表日期：2024
文献求助 收藏